The Rab25 targeting peptide, RFP14, preferentially binds to Rab25 over Rab11a and inhibits cell proliferation and migration in the breast cancer cell lines in which Rab25 is oncogenic, but augments these phenotypes in the cell lines in which it is tumour-suppressive [123]. This evidence concerns the gene RAB11A and neoplasm.